Alyeska Investment Group’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-920,931
| Closed | -$2.15M | – | 561 |
|
|
2016
Q4 | $2.15M | Sell |
920,931
-118,859
| -11% | -$277K | 0.02% | 376 |
|
|
2016
Q3 | $1.75M | Buy |
1,039,790
+172,980
| +20% | +$291K | 0.02% | 384 |
|
|
2016
Q2 | $910K | Buy |
866,810
+17,586
| +2% | +$18.5K | 0.01% | 383 |
|
|
2016
Q1 | $739K | Buy |
849,224
+26,255
| +3% | +$22.8K | 0.01% | 354 |
|
|
2015
Q4 | $996K | Buy |
822,969
+33,553
| +4% | +$40.6K | 0.01% | 333 |
|
|
2015
Q3 | $1.34M | Buy |
789,416
+173,126
| +28% | +$294K | 0.02% | 360 |
|
|
2015
Q2 | $1.28M | Buy |
+616,290
| New | +$1.28M | 0.01% | 369 |
|